Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - CASH FROM OPERATIONS
Cash from Operations TVTX - Travere Therapeutics, Inc.
-230 M
LAST VALUE
-11.12%
2 YEAR CAGR
-31.63%
5 YEAR CAGR
-17.50%
10 YEAR CAGR